The "Klebsiella Pneumoniae Infections - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
'Klebsiella Pneumoniae Infections - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Klebsiella Pneumoniae Infections development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
Key Topics Covered:
1. Report Introduction
2. Klebsiella Pneumoniae Infections Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Klebsiella Pneumoniae Infections
4. Comparative Analysis
5. Products in Clinical Stage
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
- Product Description
- Research and Development
-
Product Development Activities
Companies Mentioned
- Appili Therapeutics
- Cellceutix Corp
- Debiopharm International SA
- Evaxion Biotech ApS
- F. Hoffmann-La Roche Ltd
- FOB Synthesis Inc
- ImmunoClin Corp
- Kyorin Pharmaceutical Co Ltd
- Melinta Therapeutics Inc
- Nosopharm SAS
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/jxvvvp/klebsiella?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005910/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs
